New York City-based Ludwig Cancer Research Institute named Pat Morin, PhD, its new deputy scientific director July 12.
The Latest
Glyphosate, a cancer-causing herbicide, was found in 80 percent of urine samples from kids and adults in the U.S., the CDC's "National Health and Nutrition Examination Survey" found.
Amazon launched an FDA-approved clinical trial for its cancer vaccines.
The Lung Cancer Research Foundation established a scientific executive committee July 11 to create a strategic roadmap to guide the foundation's research investment and identify areas of unmet need.
Dhanpat Jain, MD, professor of pathology and of medicine in the field of digestive diseases at New Haven, Conn.-based Yale School of Medicine, recently was appointed to the Cancer Committee of the College of American Pathologists.
New Haven, Conn.-based Yale Cancer Center appointed Kiran Turaga, MD, division chief of surgical oncology July 6. His appointment is effective Oct. 1.
Here are the top 10 oncology stories Becker's covered in June:
Cincinnati-based Christ Hospital Health Network is joining the Dana-Farber Brigham Cancer Care Collaborative, WXVU reported July 5.
Tampa, Fla.-based Moffitt Cancer Center entered a strategic alliance July 6 with Turnstone Biologics, a biotechnology company developing immunotherapies to treat and cure solid tumors.
Flint, Mich.-based McLaren Proton Therapy Center is set to become the first in the world to offer patients proton therapy with Leo Cancer Care's upright treatment technology, it said in an email to Becker's on July 5.